CVR: 36895705
Secondary names: New Preventive ApS
DKK 1,878,462
Gross profit
Net result: DKK 76,064
Susan Alsø Holding ApS, Janet Alsø Holding ApS
CVR · view ownership and management
Director registered: Janet Alsø
CVR · 22/03/2023
View the full event history
New Cardiolab ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2015. The company is registered under the industry Speciallægers aktiviteter. The management consists of Janet Alsø and Susan Alsø. The company is owned by Susan Alsø Holding ApS and Janet Alsø Holding ApS. The company has 2 employees (2018). In 2025, the company reported a gross profit of DKK 1,878,462 and a net result of DKK 76,064 compared with DKK 1,099,197 the year before. Equity in the 2025 report amounted to DKK 300,501.
Source: annual report 2025, Danish Business Authority
New Cardiolab ApS has shown a mixed financial trajectory since its inception in 2015, with fluctuating profitability and a concerning equity position. The gross profit has generally increased, reaching 1,878,462 DKK in 2025, up from 194,894 DKK in 2021, indicating improved operational efficiency. However, the company faced a significant loss in 2023, with a profit of -379,151 DKK and negative equity of -874,760 DKK, highlighting ongoing financial instability. While gross profit margins have improved, the overall equity and profitability trends raise concerns about the company's long-term viability in the specialized medical services industry.
AI-generated summary · Generated 15/08/2026
Selskabets formål er at tilbyde forebyggende lægebehandlinger samt hermed beslægtet virksomhed.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | 1.9 mio. | 76 t. | 2.1 mio. | 301 t. | 6 | |
| 202401/01/2024 – 31/12/2024 | 1.5 mio. | 1.1 mio. | 2.7 mio. | 224 t. | 4 | |
| 202301/01/2023 – 31/12/2023 | 1.1 mio. | -379 t. | 1.1 mio. | -875 t. | 5 | |
| 202201/01/2022 – 31/12/2022 | 1.2 mio. | 180 t. | 1.2 mio. | -496 t. | 5 | |
| 202101/01/2021 – 31/12/2021 | 195 t. | 516 t. | 751 t. | -675 t. | 3 | |
| 202001/01/2020 – 31/12/2020 | 80 t. | -34 t. | 1.5 mio. | -1.2 mio. | 1 | |
| 201901/01/2019 – 31/12/2019 | 240 t. | 312 t. | 1.1 mio. | -1.2 mio. | 1 | |
| 201801/01/2018 – 31/12/2018 | 172 t. | -94 t. | 633 t. | -1.5 mio. | 1 | |
| 201701/01/2017 – 31/12/2017 | 157 t. | -454 t. | 387 t. | -1.4 mio. | 2 | |
| 201601/01/2016 – 31/12/2016 | -279 t. | -862 t. | 330 t. | -920 t. | 1 |
Compared to 654 companies in Speciallægers aktiviteter
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorNew Cardiolab ApS was founded on 18 May 2015.
New Cardiolab ApS is registered under the industry Speciallægers aktiviteter (industry code 862200).
New Cardiolab ApS had 2 employees in 2018 according to the Danish CVR register.
New Cardiolab ApS is owned by Susan Alsø Holding ApS and Janet Alsø Holding ApS.
cardiolab.dk belongs to New Cardiolab ApS, CVR number 36895705.
In 2025, New Cardiolab ApS reported a gross profit of DKK 1,878,462.
Claim this page to add your logo and social links. Free to get started.
New Cardiolab ApS has published its annual report for 2025. Gross profit came to DKK 1,878,462, and the net result was DKK 76,064.
New Cardiolab ApS has published its annual report for 2024. Gross profit came to DKK 1,483,747, and the net result was DKK 1,099,197.
New Cardiolab ApS has published its annual report for 2023. Gross profit came to DKK 1,140,118, and the net result was DKK -379,151.
New Cardiolab ApS has published its annual report for 2022. Gross profit came to DKK 1,192,181, and the net result was DKK 179,619.
As of March 22, 2023, Janet Alsø is registered as adm. dir. of New Cardiolab ApS.
As of March 22, 2023, Susan Alsø is registered as director of New Cardiolab ApS.
As of March 21, 2023, Janet Alsø has stepped down as director of New Cardiolab ApS.
New Cardiolab ApS has published its annual report for 2021. Gross profit came to DKK 194,894, and the net result was DKK 516,376.
As of November 5, 2021, Susan Alsø Holding ApS is registered as an owner of New Cardiolab ApS with an ownership share of 50%.
As of November 5, 2021, Janet Alsø Holding ApS is registered as an owner of New Cardiolab ApS with an ownership share of 50%.
New Cardiolab ApS has published its annual report for 2020. Gross profit came to DKK 80,219, and the net result was DKK -34,462.
New Cardiolab ApS has published its annual report for 2019. Gross profit came to DKK 240,346, and the net result was DKK 311,924.
New Cardiolab ApS has published its annual report for 2018. Gross profit came to DKK 172,219, and the net result was DKK -94,341.
New Cardiolab ApS has published its annual report for 2017. Gross profit came to DKK 157,000, and the net result was DKK -454,306.
New Cardiolab ApS has published its annual report for 2016. Gross profit came to DKK -279,200, and the net result was DKK -861,535.
New Cardiolab ApS has published its interim report for the period May 18, 2015 – December 31, 2015.
As of June 11, 2015, Beierholm Godkendt Revisionspartnerselskab has been appointed auditor of New Cardiolab ApS.
As of June 11, 2015, Beierholm Godkendt Revisionspartnerselskab has stepped down as auditor of New Cardiolab ApS.
As of May 18, 2015, Janet Alsø is registered as director of New Cardiolab ApS.
New Cardiolab ApS was founded on May 18, 2015.
Companies in the same industry and area
CVR 21215430
CVR 45654435
CVR 21569488
CVR 30798813
CVR 39257815
